Cite
HARVARD Citation
Koumarianou, A. et al. (n.d.). 1326PEvaluation of the efficacy and safety of everolimus as a first-line treatment in newly diagnosed patients with advanced gastroenteropancreatic neuroendocrine tumors. Annals of oncology. p. . [Online].